Good clinical practice in developing countries: applying recommendations

Area of Science:

• Clinical Research Ethics
• International Health Regulations
• Global Clinical Trials

Background:

• Clinical research recommendations for developing nations were established in 2007.
• Certain critical issues require further in-depth discussion and clarification.
• This article builds upon existing guidelines to address emerging challenges.

Purpose of the Study:

• To explore specific, underexplored ethical and logistical issues in clinical trials conducted in developing countries.
• To provide nuanced guidance on complex aspects of international research conduct.
• To enhance the ethical and operational standards of global health research.

Main Methods:

• Qualitative analysis of previously unaddressed issues in clinical research.
• Discussion and elaboration on key ethical considerations.
• Review of specific operational challenges in multinational research settings.

Main Results:

• Identified and discussed critical areas including informed consent processes.
• Addressed the dual ethics committee review requirement and standards of care.
• Examined management of biological samples, follow-up committees, and Serious Adverse Event (SAE) reporting.

Conclusions:

• There is a need for expanded guidance beyond the 2007 recommendations for clinical research in developing countries.
• Specific attention to paediatric trials and the role of Contract Research Organizations (CROs) is crucial.
• Addressing these nuanced issues will improve the quality and ethical integrity of global clinical research.